FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Taro Pharmaceuticals Desoximetasone Cream Recall

Desoximetasone Cream USP, 0

Taro Pharmaceuticals, Inc.

Risk level
Class II
Reported by FDA
Nov 9, 2016
Recall ID
D-0117-2017
Check your lot numberHow we source this data

Summary

Taro Pharmaceuticals recalled Desoximetasone Cream starting Sep 13, 2016. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0117-2017 on Nov 9, 2016. Reason: Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation). Status: Terminated.

Why it was recalled

Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation).

Product description

Desoximetasone Cream USP, 0.05% 100 g, Rx only, mfd. by Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532; NDC 51672-1271-7

Lot numbers, UPCs & expiration codes

Lot #: E0598-19624, E5099-19624, Exp. Jan 2017

Where it was sold

US & Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0117-2017
Classification
Class II
Status
Terminated
Recall initiated
Sep 13, 2016
FDA report date
Nov 9, 2016
Quantity
6,756 units
Recall type
Voluntary: Firm initiated
Recalling firm
Taro Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0117-2017, exactly as published.

Show all FDA fields
City
Brampton
Status
Terminated
Country
Canada
Event ID
75349
Address
130 East Dr
Code information
Lot #: E0598-19624, E5099-19624, Exp. Jan 2017
Report date
Nov 9, 2016
Product type
Drugs
Recall number
D-0117-2017
Classification
Class II
Recalling firm
Taro Pharmaceuticals, Inc.
Product quantity
6,756 units
Termination date
Jun 15, 2018
Reason for recall
Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation).
Voluntary / mandated
Voluntary: Firm initiated
Product description
Desoximetasone Cream USP, 0.05% 100 g, Rx only, mfd. by Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532; NDC 51672-1271-7
Distribution pattern
US & Puerto Rico
Recall initiation date
Sep 13, 2016
Initial firm notification
Letter
Center classification date
Nov 1, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0117-2017, published Nov 9, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls